|
A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. Clinical research trials and A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.. A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. clinical trial. Participants typically obtain the most effective healthcare available for their A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.  A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
For Condition: Breast Cancer
Status: Recruiting
Sponsor(s): Abbott Laboratories ,
Synopsis: The purpose of the study is to determine if ABT-751 will decrease tumors, and determine how long the tumor shrinkage can be maintained in patients with breast cancer after having had taxol or taxotere. Patients will receive ABT-751 by mouth daily for 21 days. Patients will be off drug for 7 days before starting the next cycle of drug.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Female
Protocol Entry Criteria: - Stage IIIB or IV breast cancer. - Recurrent tumor after or while on taxane therapy (taxol or taxotere). - Not pregnant or breast feeding. - Able to tolerate normal activites of daily living. - No anti-tumor therapy (including hormonal therapy or Herceptin) within 4 weeks of the start of ABT-751 administration. - Adequate bone marrow, kidney and liver function.
Total Enrollment:
Location and Contact Information:
Indiana University Cancer Center Section of of Hemtology/Oncology Indiana Cancer Pavilion *Recruiting*
Indianapolis, Indiana, 46202
United States
Recruiting Darlene Washington 317-278-3730
Oncology & Hemotology Associates of Kansas City, PA *Recruiting*
Kansas City, Missouri, 64111
United States
Recruiting Vickie Thomas 913-514-4641
Northwestern University Medical School Division of Hemtology/Oncology *Recruiting*
Chicago, Illinois, 60611
United States
Recruiting Sarah Shin 312-695-1382
Northern Indiana Cancer Research Consortium *Recruiting*
South Bend, Indiana,
United States
Recruiting Susan Haithcox 574-284-7977
Oncology-Hematology Group of South Florida *Recruiting*
Miami, Florida, 33176
United States
Recruiting Julie Reed 305-595-2141
Texas Oncology *Recruiting*
Dallas, Texas,
United States
Recruiting Jeremy Day 972-566-4392
Georgia Cancer Specialists *Recruiting*
Atlanta, Georgia,
United States
Recruiting Christopher Moore 770-496-9427
Clinical Research Network, Inc. *Recruiting*
Plantation, Florida, 33324
United States
Recruiting Cynthia Frankel 954-476-0342
Additional Information:
Study ID Numbers: M02-447;
Study Start Date:
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00063102
Other Breast Cancer Studies:
1. Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
2. Exemestane and Raloxifene in Treating Postmenopausal Women With a History of Ductal Carcinoma in Situ, Stage I, Stage II, or Stage III Breast Cancer
3. Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
4. Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
5. Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
Related Studies:
Other Breast Cancer Clinical Trials
Other Florida Clinical Trials
Other Miami Clinical Trials
A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
|
|
|
|
|
|
|
|
